by EmVenio | Mar 30, 2023 | Press Release
EmVenio doubles minority participation in clinical trials with geographic and cultural accessibility solution protected by the ClearDATA Managed Health Cloud AUSTIN, Texas, March 30, 2023 (GLOBE NEWSWIRE) — ClearDATA®, the first and most comprehensive...
by EmVenio | Mar 6, 2023 | Press Release
DURHAM, N.C., March 6, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Orlando, Florida, as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver...
by EmVenio | Mar 6, 2023 | Blog
EmVenio Research is committed to helping you achieve your DEI objectives and meet enrollment goals. With our 10 active Community Research Sites located in geographies providing access to underserved and difficult to reach populations, we enable you to enroll the...
by EmVenio | Feb 27, 2023 | Blog
The SCOPE 2023 Summit was a major success, with attendees from all over the world gathering to learn more about the latest developments in the clinical trial industry. The event was full of memorable moments, from keynotes, workshops, and demos to the SCOPE 2023 Best...
by EmVenio | Feb 21, 2023 | Press Release
DURHAM, N.C., Feb. 21, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Claremont, California, as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver...
